Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment
about
Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic reviewPerinatal antidepressant use: understanding women's preferences and concerns.Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Epigenetic basis for the development of depression in children.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Effects of maternal psychotropic drug dosage on birth outcomes.The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior.Use of psychotropic medication during pregnancy and the postpartum period.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options.Maternal pre-pregnancy obesity and gestational weight gain influence neonatal neurobehaviour.Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.Depression during gestation in adolescent mothers interferes with neonatal neurobehavior.Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring.Pregnancy and postpartum antidepressant use moderates the effects of sleep on depression.The risks and benefits of antidepressants to treat pediatric-onset depression and anxiety disorders: a developmental perspective.Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
P2860
Q30395001-F3953A61-419C-4424-93A1-9B08D1AE4CBCQ34544981-D4A4C91E-1AA6-4BE7-887D-A1534877C3AFQ34775567-93B0CD1D-70B9-4992-916D-B4E2B2FEC3C0Q34778571-EE4AD60A-D28A-4185-9498-43B8D860F230Q36547279-5D37B33A-1D90-4423-9AFB-E328D9D6F8EDQ36921232-B7F77E10-6C75-4EC7-9F7A-67C8CE174E18Q37192260-FE526E35-8877-42DE-B874-8205CD579578Q37337705-19B43CDD-7DCD-4632-A718-8380341CF8DFQ37397151-585B07F8-11BC-4452-A4D9-A30B46B56007Q37600917-2E0CD2A7-332D-4977-8E9B-F6D3C1FB8F41Q38155675-A165751F-2084-44A7-84A6-1F4B08A3FFC4Q38215072-C5C82755-9333-4EE8-B9D9-F703453F723CQ38231015-02D0AEB0-833A-4370-A706-EED09C079315Q38830529-855B425C-0F6A-4BCD-8741-2C0BAAC37A2FQ38857229-E73FE3FD-FDC3-48F5-A964-C581DE274F41Q40162771-EA2A92CD-629B-4873-B5B4-0E6F936BC709Q42018860-1571AF49-71D9-4F47-B091-AB6CFE97C146Q42444090-5C36FFB3-670C-4254-989D-6E6AE5763353Q47608827-2BDCD959-A1CC-4B2A-AA8E-A9B25C87A3D5Q47727805-BD71E0D0-F9D5-441D-9D99-E8BB3FAFB429Q48491094-C3C67E7C-24F8-4E89-BF7E-A472303BEF34Q49494105-73D680C6-3CE8-4424-8B07-DCF8899BCB3E
P2860
Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@ast
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@en
type
label
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@ast
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@en
prefLabel
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@ast
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@en
P2093
P2860
P356
P1476
Newborn neurobehavioral patter ...... n reuptake inhibitor treatment
@en
P2093
Amy L Salisbury
Cynthia L Battle
Katherine L Wisner
Laura Stroud
Teri Pearlstein
P2860
P304
P356
10.1002/DA.20883
P50
P577
2011-09-02T00:00:00Z